DOW JONES21,636.78-915.39 -4.06%
S&P 5002,541.47-88.60 -3.37%
NASDAQ7,502.38-295.16 -3.79%

Eiger BioPharmaceuticals Q4 EPS $(0.69) Up From $(0.92) YoY

Eiger BioPharmaceuticals (NASDAQ:EIGR) reported quarterly losses of $(0.69) per share. This is a 25 percent increase over losses of $(0.92) per share from the same period last year.

Benzinga · 03/13/2020 12:02

Eiger BioPharmaceuticals (NASDAQ:EIGR) reported quarterly losses of $(0.69) per share. This is a 25 percent increase over losses of $(0.92) per share from the same period last year.